CLCN2

Chr 3ADAR

chloride voltage-gated channel 2

Also known as: CIC-2, CLC2, ECA2, ECA3, EGI11, EGI3, EGMA, EJM6

This gene encodes a voltage-gated chloride channel. The encoded protein is a transmembrane protein that maintains chloride ion homeostasis in various cells. Defects in this gene may be a cause of certain epilepsies. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismAD/ARLOEUF 0.775 OMIM phenotypes
Clinical SummaryCLCN2
🧬
Gene-Disease Validity (ClinGen)
epilepsy · ADRefuted

Refuted — evidence has disproved this relationship

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
46 unique Pathogenic / Likely Pathogenic· 370 VUS of 706 total submissions
📖
GeneReview available — CLCN2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.77LOEUF
pLI 0.000
Z-score 2.83
OE 0.55 (0.410.77)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.65Z-score
OE missense 0.92 (0.850.99)
494 obs / 536.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.55 (0.410.77)
00.351.4
Missense OE?0.92 (0.850.99)
00.61.4
Synonymous OE?1.09
01.21.6
LoF obs/exp: 26 / 46.9Missense obs/exp: 494 / 536.6Syn Z: -0.97
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveCLCN2-related leukoencephalopathy with ataxiaLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.80top 10%
GOF
0.78top 25%
LOF
0.2386th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Literature Evidence

GOFA gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 29403012

ClinVar Variant Classifications

706 submitted variants in ClinVar

Classification Summary

Pathogenic22
Likely Pathogenic24
VUS370
Likely Benign204
Benign23
Conflicting29
22
Pathogenic
24
Likely Pathogenic
370
VUS
204
Likely Benign
23
Benign
29
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
16
6
0
0
22
Likely Pathogenic
21
3
0
0
24
VUS
5
334
19
12
370
Likely Benign
0
16
88
100
204
Benign
0
4
15
4
23
Conflicting
29
Total42363122116672

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

42 pathogenic / likely-pathogenic (of 48) ClinVar copy-number / structural variants overlap CLCN2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CLCN2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →